FTO was also overexpressed in BCa (particularly in human epidermal growth factor receptor 2 (HER2)-positive tumors) and was also shown to play a role in triple-negative, pan-resistant, inflammatory breast cancer cell lines [50,51]. This evidence concerns the gene ERBB2 and breast cancer.